Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain.
about
Evolving paradigms in the treatment of opioid-induced bowel dysfunctionConsensus Recommendations on Initiating Prescription Therapies for Opioid-Induced ConstipationEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenTapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data.Perilla extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study.Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipationOpioid-Induced Constipation.Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxoneA randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.Behavioral risk factors of constipation in palliative care patients.Efficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate responseThe Impact of Opioid Treatment on Regional Gastrointestinal Transit.Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review.Can wheat germ have a beneficial effect on human health? A study protocol for a randomised crossover controlled trial to evaluate its health effects.Opioid-induced constipation: challenges and therapeutic opportunities.Validated tools for evaluating opioid-induced bowel dysfunction.Constipation assessment scales in adults: a literature review including the new Bowel Function Index.Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.New treatment options for chronic constipation: mechanisms, efficacy and safety.The role of surgery in chronic constipation: when and why.Opioid-induced bowel dysfunction: pathophysiology and management.Quantification and variability in colonic volume with a novel magnetic resonance imaging method.An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female anorectal dysfunction.Assessment of a Stool Symptom Screener and Understanding the Opioid-Induced Constipation Symptom Experience.Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study.Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation.Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials.Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study.Oral prolonged-release oxycodone/naloxone for managing pain and opioid-induced constipation: A review of the evidence.Stapled trans-anal rectal resection (STARR) in the surgical treatment of the obstructed defecation syndrome: results of STARR Italian Registry.The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients.Reliability and validity of the Bowel Function Index for evaluating opioid-induced constipation: translation, cultural adaptation and validation of the Portuguese version (BFI-P).Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.Should we preserve the inferior mesenteric artery during sigmoid colectomy?Validation of a bowel function diary for assessing opioid-induced constipation.Opioid misuse in gastroenterology and non-opioid management of abdominal pain.Effects of a proposed physical activity and diet control to manage constipation in middle-aged obese women.Assessment of Constipation in Patients With Cancer.The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference.
P2860
Q26777692-810B9C8A-570D-4D25-A89C-6C66533929ADQ26830397-3A67D33A-C3CA-4304-9D78-56CF773A96F1Q27010907-71AB5A68-6157-4711-A4FD-BB9B41E95019Q28209970-40054200-461B-4814-BF3B-32E56761B753Q31128284-D1BBCFD4-F901-4ACB-A7E9-6E5C774E9AC5Q33687137-BD5C3A2C-F00A-4A3C-A7A7-EC5DA0236219Q34146166-7D970AAA-25EC-40CB-806C-128F08F94474Q34497803-71BD3831-83B9-40EE-82FF-C5AD2FB938C3Q34798408-2B28E339-34BE-463E-BFF9-4C766C9B1C9EQ35664979-16762382-4054-4B2B-A8FA-5906235CA1EEQ36012606-551A9EBF-077F-436F-824F-3FE55C01B0B8Q36223541-F0680A87-1284-4C14-B9A8-F0FC4339BA75Q36762661-58DB5853-E59A-46F7-BEA1-38104D5FD427Q36930788-6C0BF73B-A304-4300-A9E1-052A4B3564B1Q37454817-94FDA647-2435-4F88-B91F-7C58693AFD50Q37846099-0C01468A-C7BE-4EB4-9008-F31281A0B014Q37857765-23BD285A-6042-4863-B1FF-9C10917819A3Q37930644-2B7F9D10-A904-4B18-B6CB-31FCCC9DF68DQ37954521-B105C818-8C65-4E87-A23E-0A640147AF11Q37960501-6BEFFC69-8B8B-4209-9C60-C09D7B997D81Q37968011-DC84D3A3-A5BD-46D0-ADF0-01DE4DDE3163Q38040843-828D919F-12D6-45B7-A05B-ED6F3E0E93E1Q38939634-0F9D49EC-E369-4119-BD89-ED80174DCEEEQ38988112-0E8EDB61-774C-414B-9C78-0E1C6945B2D1Q39127343-5D11E8A4-B49D-498A-AFC7-26E2EAE68CA3Q39155270-345EC906-1F81-4BE4-81C2-E6C32B3DBC82Q39197018-61387E71-BA83-466C-82E8-5517B0A872CFQ42669709-AA4C84B7-60F6-4142-8251-9524E1B2CCD9Q43005382-76CDD280-4D7F-4321-A203-23387AA60798Q43075972-E3A471E0-1809-40A1-995F-DA612A6C869CQ43326296-38669C22-56B8-4358-B16E-7231E91491DBQ43330788-640FC9AF-90AE-4644-86C2-B936C5B7F598Q43357590-EB792882-896A-4C46-8485-1A50CB9C93B2Q43365484-F3CF4224-C5D6-41AE-A372-CB34232D8BB9Q43369360-12546FB8-BF1A-4FCA-A8BF-489B82FB4E13Q44348353-36F458B4-C35B-464E-9F12-E3D569613622Q44350905-0785205E-C798-4485-9F8B-D30F32DD1AE8Q47098172-75615D5A-FE85-41ED-ADF4-DF853F08DA0AQ47103964-842A2ECD-4A26-4638-B625-E411D34FB316Q47852722-15C3C47D-BDA9-4C3A-B074-BA3C17E170A3
P2860
Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Validation of the PAC-SYM ques ...... ts with chronic low back pain.
@en
Validation of the PAC-SYM ques ...... ts with chronic low back pain.
@nl
type
label
Validation of the PAC-SYM ques ...... ts with chronic low back pain.
@en
Validation of the PAC-SYM ques ...... ts with chronic low back pain.
@nl
prefLabel
Validation of the PAC-SYM ques ...... ts with chronic low back pain.
@en
Validation of the PAC-SYM ques ...... ts with chronic low back pain.
@nl
P2093
P2860
P921
P1476
Validation of the PAC-SYM ques ...... ts with chronic low back pain.
@en
P2093
Dominique Dubois
Dorothy L Keininger
Karen Simpson
Robert Slappendel
P2860
P304
P356
10.1016/J.EJPAIN.2005.03.008
P577
2006-04-01T00:00:00Z